Wall Street expects a year-over-year increase in earnings on higher revenues when Nuvation Bio Inc. (NUVB) reports results ...

Mirai Bio to Unveil Two Next Generation Programs for Targeted Nucleic Acid Delivery Beyond the Liver at ASGCT 2026 ...

Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035 at a 19.3% CAGR during the forecast period for 2026 ...

A patent-protected Lipo-Nano-emulsion platform that lets brands take clean-label SKUs from concept to physical sample ...

Researchers have created a 3D programmable device merging living neurons with flexible electronics, achieving high-efficiency ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching targeted cell therapies designed specifically for patients with autoimmune diseases, ...

Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily pretreated PTCL population ...

For this action, the firm cited the potential of Nuvation Bio’s glioma drug candidate, safusidenib. First, RBC Capital ...

The MDI Biological Laboratory in Bar Harbor is a leader in regeneration science and medicine. The institution recently ...

A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...